{"id":23578,"date":"2026-02-23T16:27:09","date_gmt":"2026-02-23T16:27:09","guid":{"rendered":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/2026\/02\/23\/novo-nordisk-studien-flop-bei-neuem-abnehmmittel-aktie-im-freien-fall\/"},"modified":"2026-02-23T16:27:09","modified_gmt":"2026-02-23T16:27:09","slug":"novo-nordisk-studien-flop-bei-neuem-abnehmmittel-aktie-im-freien-fall","status":"publish","type":"post","link":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/2026\/02\/23\/novo-nordisk-studien-flop-bei-neuem-abnehmmittel-aktie-im-freien-fall\/","title":{"rendered":"Novo Nordisk: Studien-Flop bei neuem Abnehmmittel, Aktie im freien Fall"},"content":{"rendered":"<p>Novos neues Abnehmmedikament schneidet in einer Studie deutlich schlechter ab als das des US-Unternehmens Eli Lilly \u2013 der Konkurrent scheint endg\u00fcltig davonzuziehen. Die Novo-Aktie fiel auf den tiefsten Stand seit 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novos neues Abnehmmedikament schneidet in einer Studie deutlich schlechter ab als das des US-Unternehmens Eli Lilly \u2013 der Konkurrent scheint endg\u00fcltig davonzuziehen. Die Novo-Aktie fiel auf den tiefsten Stand seit 2021.<\/p>\n","protected":false},"author":1,"featured_media":23579,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-23578","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts\/23578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/comments?post=23578"}],"version-history":[{"count":0,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts\/23578\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/media\/23579"}],"wp:attachment":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/media?parent=23578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/categories?post=23578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/tags?post=23578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}